Please login to the form below

Not currently logged in

DH appoints new board members

Dr Catherine Bell and Dr David Heymann are to join the departmental board of the UK's Department of Health as non-executive board members

Dr Catherine Bell and Dr David Heymann are to join the departmental board of the UK's Department of Health (DH) as non-executive board members.

Dr Heymann, who has previously worked for the Centres for Disease Control and Prevention (USA) and the World Health Organisation (WHO), is currently chair of the Health Protection Agency (HPA), an independent body in the UK set up in 2003 to provide advice and information to the public and healthcare professionals about infectious diseases and environmental hazards.

As announced in October 2010, the HPA is one of 11 DH-related bodies to be abolished by the coalition government as part of efforts to reform the way public services are managed.

With his appointment lasting until April 2012, Heymann will support the transfer of the agency's functions to the DH with plans to incorporate its services into Public Health England - a dedicated public health service proposed in the Health and Social Care Bill.

Dr Bell, whose previous roles in Whitehall include being permanent secretary of the Department of Trade and Industry, is governor of the London School of Economics and chair of the Investment Committee of the Civil Service Benevolent Fund.

Both Dr Bell and Dr Heymann will help the DH oversee health reforms in England, with board duties including providing advice to ministers on the strategy and objectives for the health and social care system; setting DH standards and establishing frameworks for governance and management of risk.

Current board members include chief medical officer, Dame Sally Davies, and Sir David Nicholson, chief executive of the NHS.

26th January 2011

From: Healthcare


Featured jobs

Subscribe to our email news alerts


Add my company
Virgo Health

Virgo Health is an award-winning global healthcare communications and medical education agency comprising specialists with some of the best skills,...

Latest intelligence

Report: Achieving launch excellence in the challenging healthcare markets of today
Our in-depth report is based on original data and expert interviews, which coupled with our own experience, ensures we give you the best recommendations for achieving launch success in challenging...
What is blockchain and why should i care - Richard Springham
Four Health - Emerging Technologies The power of blockchain lies in the fact it can prove that a unique event occurred at a certain time with out the need to...
NHS medicines optimisation milestone
Steve How, Paul Midgley and Oli Hudson, of the Wilmington Healthcare Consulting Team, explore the implications of Adalimumab’s recent European patent expiry...